Naltrexone is under development for the treatment of alcohol, opioid addiction and methamphetamine use disorder (MUD). It is a long acting implantable naltrexone implant, administered by the ...
Companies like Pfizer, Amgen, AbbVie, Novartis, and others are advancing Opioid Use Disorder treatments, focusing on improving symptoms and patient ...